[Interleukin-2 in the treatment of malignant diseases: results and perspectives]
Related Experiment Videos
1Laboratoire d'Hémato-Immunologie, Institut Gustave-Roussy, INSERM U 333, Villejuif, France.
Pathologie-Biologie
|October 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patients.
Journal of immunotherapy (Hagerstown, Md. : 1997)·1999
A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion.
European journal of immunology·1999
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.
Leukemia & lymphoma·1998
Biological diagnosis of diabetes mellitus.
Pathologie-biologie·2015
Prospects and Challenges in Defining Risk-reducing Medications for the Prevention of BRCA1/2-associated Breast Cancer.
Cancer prevention research (Philadelphia, Pa.)·2026
Ginsenoside Rg1 Alleviates Chronic Obstructive Pulmonary Disease Partially Through Regulating ABCB1-Mediated Mitochondrial Dysfunction.
Journal of biochemical and molecular toxicology·2026